RxDoctor Payments Data

Robert Allen

Vascular Surgery · Kingsport, TNNPI 1578791307

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (33.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 84.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $14,459 and has fallen 92.1% since, to $1,146 in 2025. Among vascular surgery clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$50,593in general payments, 2019–2025

Across 391 payments — averaging $129.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$43K
  • W. L. Gore & Associates, Inc.$2K
  • Cook Medical LLC$2K
  • Cook Incorporated$764
  • Bolton Medical Inc$708
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$354
  • plus $2K from 18 others
$96,109in research payments, 2019–2025

Across 22 payments — averaging $4368.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bolton Medical Inc$67K
  • W. L. Gore & Associates, Inc.$29K

What the payments were for

  • Consulting fees$13,48827%
  • Speaking & faculty fees$17,14434%
  • Travel & lodging$7,96416%
  • Food & beverage$11,83123%
  • Education$1680%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,593 in reported general payments places this provider in the 90th percentile of 117 vascular surgery providers in Tennessee.

See all vascular surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$93,259
Medicare patients
286
Services billed
528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban13$11,372
EliquisApixaban16$10,445
ClopidogrelClopidogrel Bisulfate186$1,366
Cilostazol46$722
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$101
Rosuvastatin Calcium13$51

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →